- Home
- PBHC vs IBIO Comparison
PBHC vs IBIO Comparison
Compare PBHC & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBHC | IBIO |
|---|---|---|
| Founded | 1859 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 72.2M |
| IPO Year | 2014 | 2009 |
Fundamental Metrics
Financial Performance| Metric | PBHC | IBIO |
|---|---|---|
| Price | $12.75 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.75 |
| AVG Volume (30 Days) | 3.0K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | 46.25 | ★ 73.08 |
| EPS | ★ 0.47 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $27.13 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.06 | $0.56 |
| 52 Week High | $16.89 | $4.19 |
Technical Indicators
Market Signals| Indicator | PBHC | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 31.79 |
| Support Level | $12.06 | $1.70 |
| Resistance Level | $13.76 | $1.81 |
| Average True Range (ATR) | 0.19 | 0.22 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 0.00 | 22.05 |
Price Performance
Historical ComparisonAbout PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.